Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population-based cohort study.

Yin-Hsi ChangLi-Nien ChienWan-Ting ChenI-Chan Lin

Published in: PloS one (2022)

No significant differences in the risk of major ATEs and glaucoma were found between ranibizumab and aflibercept, and aflibercept might be safe for use in elderly patients.

Keyphrases

ultrasound guided
age related macular degeneration
optic nerve
diabetic retinopathy
atrial fibrillation
human health
cataract surgery
climate change
optical coherence tomography
clinical evaluation